Abstract
As thrombolytic therapy developed as a potential intervention for acute ischemic stroke during the 1980s, early clinical investigation depended upon pretreatment cerebral arteriography [5]. The pathologic cerebral anatomy was first defined, and then thrombolytic therapy could be administered selectively to the site of thrombosis via the intra-arterial route [3, 6, 11]. These intra-arterial thrombolytic interventions, carried out with the benefit of computed tomographic (CT) scanning to exclude hemorrhagic stroke, demonstrated the feasibility of cerebral arterial clot lysis. Several thrombolytic agents administered in a variety of doses [3–6, 11–13] were shown to accomplish partial or complete arterial recanalization in the setting of acute cerebral embolism or thrombosis.
This work was supported in part by the National Institute of Neurological Disorders and Stroke.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brott T, Haley EC, Levy D, Barsan W, Broderick J, Marler JR (1991) Strategies for early treatment of acute cerebral infarction. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer-Verlag, Berlin Heidelberg New York, p 196
Brott TG, Haley EC, Levy DE, et al (1992) Urgent therapy for stroke. Part I. Pilot study of tissue plaminogen activator administered within 90 minutes. Stroke 23:632–640
del Zoppo GJ, Ferbert A, Otis S, et al (1988) Local intra-arterial therapy in acute carotid territory stroke: A pilot study. Stroke 19:307–313
del Zoppo GJ, Poeck K, Pessin MS, and 16 coauthors of the rt-PA Acute Stroke Study Group (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32:78–87
del Zoppo GJ, Zeumer H, Harker LA (1986) Thrombolytic therapy in acute stroke: Possibilities and hazards. Stroke 17:595–607
Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19:1216–1222
Haley EC, Levy DE, Brott TG, et al (1992) Urgent therapy for stroke. Part II. Pilot study of plasminogen administered 91 — 180 minutes from onset. Stroke 23:641–645
Haley EC, TPA Bridging Study Group (1992) Pilot randomized trial of tissue plaminogen activator in acute ischemic stroke (abstract). Neurology 42(Suppl 3):203
Marder VJ, Sherry S (1988) Thrombolytic therapy. Current status. N Engl J Med 388:1512–1520,–1585–1595
Marler JR, Brott T, Haley EC, Levy D (1991) Evaluation of tissue plasminogen activator early in the course of acute ischemic stroke. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer-Verlag, Berlin Heidelberg New York, p 152
Mori E, Tabuehi M, Yoshida T, Yamadori A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19:802–812
Mori E, Yoneda Y, Tabuchi M, et al (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42:976–982
von Kummer R, Forsting M, Sartor K, Hacke W (1991) Intravenous recombinant tissue plaminogen activator in acute stroke. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer-Verlag, Berlin Heidelberg New York, p 161
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Brott, T. (1993). Symptom-Based Trials of Intravenous rt-PA in Acute Stroke. In: del Zoppo, G.J., Mori, E., Hacke, W. (eds) Thrombolytic Therapy in Acute Ischemic Stroke II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78061-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-78061-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56442-3
Online ISBN: 978-3-642-78061-5
eBook Packages: Springer Book Archive